Pancreatic cancer

Published on November 30, 2016   47 min

Other Talks in the Series: Gastroenterology and Hepatology

Hi, I'm Dr. Randall Brand. I'm Professor of Medicine at the University of Pittsburgh Medical Center in the Division of Gastroenterology, Hepatology and Nutrition. It's my pleasure to discuss with you today on the topic of pancreatic cancer.
My talk today will review some general background on pancreatic cancer, highlighting risk factors for the disease, how it clinically presents, some of the common diagnostic modalities used in pancreatic cancer, review pancreatic cystic lesions, the staging of the disease, treatment, and then some of our current needs for the disease.
Worldwide pancreatic cancer causes over 300,000 deaths. In the United States, it's estimated that there will be over 53,000 new patients diagnosed with pancreatic cancer, with majority of these dying with a predicted almost 42,000 deaths. In the United States, there's about 1.4% lifetime risk of developing pancreatic cancer, and it's currently the third leading cause of cancer-related mortality in the United States. The vast majority of the tumors are adenocarcinomas accounting for over 90% with other types including neuroendocrine, acinar, and lymphomas. My talk today will be focusing on adenocarcinomas.